Protalix BioTherapeutics (PLX) Share-based Compensation (2010 - 2026)
Protalix BioTherapeutics' Share-based Compensation came in at $398,000 for Q2 2026, down 6.8% from $427,000 a year earlier and down 25.2% from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Share-based Compensation (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Protalix BioTherapeutics reported Share-based Compensation of $2.26 million, up 0.8% year-over-year; for FY2025, it came in at $2.3 million, down 29.4% from FY2024.
- Share-based Compensation carries a five-year compound annual growth rate of -6.0% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $3.25 million in FY2024 (-5.7%), $3.45 million in FY2023 (+65.4%), $2.09 million in FY2022 (-12.2%) and $2.38 million in FY2021 (-24.0%).
- The Q2 2026 figure represents the lowest quarterly Share-based Compensation since Q2 2022.
- Year-over-year, Share-based Compensation increased in 1 of the last eight quarters, with an average decline of 24.7%.
- The fastest year-over-year change in Share-based Compensation over five years came in Q3 2023 (growth of 160.0%), and the weakest in Q3 2021 (a decline of 60.2%).
- Business Quant data shows PLX's Share-based Compensation at $532,000 (Q1 2026), $732,000 (Q4 2025) and $598,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Protalix BioTherapeutics | 207.16 Mn | 55.78 Mn | 12.13 Mn | 398,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 398,000.00 |
| Mar 31, 2026 | 532,000.00 |
| Dec 31, 2025 | 732,000.00 |
| Sep 30, 2025 | 598,000.00 |
| Jun 30, 2025 | 427,000.00 |
| Mar 31, 2025 | 540,000.00 |
| Dec 31, 2024 | 654,000.00 |
| Sep 30, 2024 | 620,000.00 |
| Jun 30, 2024 | 998,000.00 |
| Mar 31, 2024 | 981,000.00 |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 438,000.00 |
| Mar 31, 2023 | 546,000.00 |
| Dec 31, 2022 | 539,000.00 |
| Sep 30, 2022 | 422,000.00 |
| Jun 30, 2022 | 288,000.00 |
| Mar 31, 2022 | 836,000.00 |
| Dec 31, 2021 | 418,000.00 |
| Sep 30, 2021 | 563,000.00 |
API Access
Protalix BioTherapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();